Women without risk factors for blood clots, venous thromboembolism (VTE), who are taking the third-generation oral contraceptive drospirenone found in YAZ, Yaz 28, Yazmin, Beyaz, Zarah, Gianvi, and Ocella have an increased risk for nonfatal blood clots, VTE, compared with women taking the second-generation contraceptive levonorgestrel, according to the findings of 2 new case-control studies.
Tags: AZ, Beyaz, Blood Clots, Dr. Mathews, Gianvi, new, Ocella, oral contraceptive, VTE, women, YAZ, Yaz 28, Yazmin, Zarah
Posted in Gynecology, News & Education, Our Blog | No Comments »